InsidersTradesSigma
Follow the GC메디아이 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, GC메디아이 has recorded 5 insider filings. Market capitalisation: €146bn. The latest transaction was reported on 8 May 2026 (Other). Among the most active insiders: GC케어. All data is openly available.
4
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
n/a
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 1,165 of 29,063 companies
80.2
score / 100
Value84
Quality76
FCF yld3.5%
Earn yld23%
EV/EBITDA3.9x
ROE·
Gross mgn52%
Net mgn19%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 May 2026
关于 GC메디아이
GC메디아이是一家在XKRX市场上市的医疗保健和制药公司。它专注于开发创新的医疗解决方案。